We are live on
!
Find out more
VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
This Quarter
Est. Return
+22.05%
1 Year Est. Return
+261.03%
3 Year Est. Return
+648.19%
5 Year Est. Return
+623.84%
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$2.93M
(+2.5%)
Cap. Flow
-$20M
Cap. Flow
% of AUM
-16.59%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Precision BioSciences
DTIL
|
+$8.88M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$7.16M |
| 3 |
VYNE Therapeutics
VYNE
|
+$3.92M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
1
DELISTED
Akero Therapeutics
AKRO
| $78.5M | 65.27% |
3,150,019
| – | – |
|
|
2
Precision BioSciences
DTIL
$216M
| $23.3M | 19.33% |
93,053
-40,544
| -30% | -$8.88M |
|
|
APLS
3
DELISTED
Apellis Pharmaceuticals
APLS
| $16.4M | 13.62% |
501,584
| – | – |
|
|
VRNA
4
DELISTED
Verona Pharma
VRNA
| $2.14M | 1.78% |
456,770
| – | – |
|
|
5
VYNE Therapeutics
VYNE
$26M
| – | – |
-20,299
| Closed | -$3.92M |
|
|
TPTX
6
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-160,333
| Closed | -$7.16M |
|
Similar funds
OCWP
FFP
BDA
PHC
OFCM
SA
ACC
NRCM